Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A patient developed a blister at the injection site after hepatitis C treatment.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

Type I interferons play a key role in the development of various skin diseases.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Interferon therapy improves quality of life for chronic hepatitis B patients.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Skin spheroids with both outer and inner layers are key for regrowing skin patterns and hair.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Exosomes could revolutionize skin disease treatment and healing.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

PEG and keratin scaffolds can effectively deliver protein drugs by controlling release based on pH levels.

The new GelMet hydrogel can effectively support skin cell growth for tissue engineering.

Finasteride's solubility and bioavailability improved by forming solid dispersions and inclusion complexes.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Curcumin-based polyurethanes with more PEG improve curcumin release and maintain strong antioxidant and antibacterial properties.

The new hydrogel with curcumin speeds up wound healing safely and effectively.